🇺🇸 Dronabinol Capsules in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Dronabinol Capsules on 1 July 2016

Marketing authorisation

FDA — authorised 1 July 2016

Application: NDA205525
Marketing authorisation holder: WELLHOUSE PHARMA
Local brand name: SYNDROS
Indication: SOLUTION — ORAL
Status: approved

Read official source →

Frequently asked questions

Is Dronabinol Capsules approved in United States?

Yes. FDA authorised it on 1 July 2016.

Who is the marketing authorisation holder for Dronabinol Capsules in United States?

WELLHOUSE PHARMA holds the US marketing authorisation.